Cogstate Ltd ( (AU:CGS) ) has provided an announcement.
Cogstate Ltd has announced an update on its ongoing on-market buy-back program, revealing that a total of 2,309,121 ordinary fully paid securities have been bought back prior to the previous day, with an additional 26,464 securities purchased on the previous day. This buy-back initiative is part of Cogstate’s strategy to optimize its capital structure, potentially enhancing shareholder value and signaling confidence in the company’s financial health.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in cognitive science and technology solutions. The company focuses on developing products and services that assess and monitor cognitive function, catering primarily to clinical trials, healthcare, and research markets.
YTD Price Performance: 27.65%
Average Trading Volume: 10,744
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $149.3M
For an in-depth examination of CGS stock, go to TipRanks’ Stock Analysis page.